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Abstract
Background: The present study focuses on the analysis of social, clinical and hospital characteristics that can lead
to disparities in the management and outcome of care. To that end, indicators of the quality of initial treatment
delivered to newly-diagnosed colorectal cancer patients in a North-Western Region of Italy, were investigated
using administrative data.
Methods: The cohort includes all incident colorectal cancer patients (N= 24,187) selected by a validated algorithm
from the Piedmont Hospital Discharge Record system over an 8-year period (2000–2007).
Three indicators of quality of care in this population-based cohort were evaluated: the proportion of preoperative
radiotherapy (RT) and of abdominoperineal (AP) resection in rectal cancer patients, and the proportion of
postoperative in-hospital mortality in colorectal cancer patients.
Results: Among rectal cancers, older patients were less likely to have preoperative RT, and more likely to receive
an AP resection compared to younger patients. The probability of undergoing preoperative RT and AP resection
was reduced in females compared to males (odds ratio (OR) 0.77, 95% confidence interval (CI) 0.64-0.93 and OR
0.78, 95%CI 0.69-0.89, respectively). However, there was a trend of increasing RT over time (p for trend <0.01).
The probability of undergoing AP resection was increased in less-educated patients and in hospitals with a low
caseload.
A higher risk of postoperative in-hospital mortality was found among colorectal cancer patients who were older,
male, (female versus male OR 0.71, 95%CI 0.60-0.84), unmarried (OR 1.32, 95%CI 1.09-1.59) or with unknown
marital status.
Conclusions: The study provides evidence of the importance of social, clinical and hospital characteristics on
the equity and quality of care in a Southern European country with an open-access public health care system.
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Background
Colorectal cancer is a common malignancy and its inci-
dence is increasing in industrialized countries [1]. While
there are several studies on new drugs for colorectal
cancer [2-4], fewer studies have been conducted to
assess the appropriateness and equity of care provided
to colorectal cancer patients at a population level [5-7].
Administrative data provide information on quality of
care, and monitor indicators of care that can be used for
assessment at a population- and hospital-level [8,9]. The
linkage of different administrative sources provides an
efficient method for gathering data on individual pat-
terns of care [10]. Although clinical data available in
administrative databases are considered limited in accur-
acy [11], their validity should be specifically assessed, as
variations exist not only between countries and periods,
but also between variables included. The use of adminis-
trative data in the assessment of quality of care among
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colorectal cancer patients is common in the United
States [12,13], Canada [14] and Northern Europe (United
Kingdom, Sweden and Denmark) [6,7,15]. To our know-
ledge, there are no published population-based studies on
the quality of care among colorectal cancer patients in
Southern Europe.
Preoperative radiotherapy (RT) in stage II or III rectal
cancer has been recommended by regional guidelines
since 2001 [16] and recently confirmed [17] to aid in the
reduction of local recurrences and tumor shrinkage
before surgery. In the last 10 years in Europe, total
mesorectal excision with sphincter-sparing procedure is
the preferred choice over sphincter-ablating procedures.
The shift toward sphincter-sparing procedures with the
preservation of normal bowel activity is the result of
several studies that have indicated similar outcomes [12]
and improved quality of life [13,18-20]. An abdomino-
perineal (AP) resection, which denotes permanent colos-
tomy, is unavoidable in some circumstances. However,
surgeons with a higher caseload of rectal cancer patients,
have been shown to perform a lower proportion of
AP resections and have patients with better survival
[14,15,21-23]. Finally postoperative in-hospital mortality
has frequently been used as a measure of quality of care,
but careful risk adjustment is needed to minimize the
role of unbalanced case-mix distribution between provi-
ders [24]. All these indicators have been used in several
studies that analyzed hospital statistics [7,14,25].
The present study focuses on the analysis of non-clinical
factors that can lead to disparities in the management and
outcome of care. To that end, social, clinical and hos-
pital determinants of the quality of initial treatment
delivered to newly-diagnosed colorectal cancer patients
who underwent a surgical procedure between 2000 and
2007 in the Piedmont Region (North-Western Italy)
were investigated, using routinely available administra-
tive data.
Methods
Study population
The study cohort of incident colorectal cancer cases in
the resident population of the Piedmont Region (about
4.3 million inhabitants) was identified from the Pied-
mont Hospital Discharge Record (HDR) system over an
8-year period using a validated algorithm [26] based on
combinations of diagnostic and surgical procedure codes
according to the International Classification of Diseases,
9th Revision, Clinical Modification (ICD-9-CM). The
HDR system routinely collects both inpatients and day-
care activity from all regional private and public hospi-
tals publicly funded. The Italian National Health Service
covers the entire population and private funding is
residual, particularly for life-threatening diseases like
cancer. Providers, both public and private, including
hospitals outside the region, to be reimbursed by the
NHS need to deliver a Hospital Discharge Record. As a
consequence, all the in-patient and day-care activities
are included in the database for administrative purpose.
Patient’s HDRs are identified by means of an encrypted
unique identification code based on the tax identification
number. Multiple records relative to each patient are
linked by means of this encrypted code.
Among all patients discharged between January 1,
2000 and December 31, 2007 with a surgical diagnosis-
related group (DRG) claim, those with a diagnosis of ma-
lignant neoplasm of the colon (ICD-9-CM: 153.0-153.9)
or malignant neoplasm of the rectum or rectosigmoid
junction (ICD-9-CM: 154.0-154.1, 154.8) were selected
(N= 29,248). Of this cohort, patients with potentially
prevalent cancer (those who had been hospitalized at any
time during the previous 5 years with either colon or
rectal cancer), as well as those with a history of colorec-
tal cancer (ICD-9-CM V10.05-V10.06), were excluded
(N= 3,946).
Of the remaining 25,302 incident colorectal cancer
cases, an additional 1,115 cases (4.4%) that were dis-
charged from extra-regional hospitals were excluded
(Figure 1). Patients were classified as colon cancer and
rectal cancer patients on the basis of the site of the
tumors. The 142 patients with a double lesion in colon
and rectum were classified as rectal cancer patients.
Patient characteristics
The HDR system routinely includes patient’s demographic
data, admission and discharge dates, admission referral
source, discharge status, up to six ICD-9-CM discharge
diagnostic and procedure codes, the regional code of the
facility, the diagnosis-related group and its tariff.
Firstly, the surgical approach was classified as palliative
or curative; this last group was then split according to
the surgical procedure performed: AP resection (ICD9:
48.5, 48.62) or other resections (ICD9: 45.4x-45.8x,
48.3x-48.4x, 48.61, 48.63-48.69). Cases were classified as
having concomitant obstruction (ICD-9-CM 560.9), per-
foration (ICD-9-CM 569.83), or an emergency admission
(OPE) or not.
Using all the diagnosis codes from the first surgical ad-
mission, disease staging [27] was used to classify patients
into two broad categories, according to the absence
or presence of loco-regional or distant metastases. To
maximize ascertainment of comorbidity, all hospital
discharges that occurred within 12 months before the
indexed surgical admission were identified, and all the
coded diagnoses used to calculate comorbidity by the
Charlson index (hereafter referred to as comorbidity), as
adapted by Romano et al. for use with claims data [28].
Additionally, for each patient, the risk-of-mortality
score was calculated using the 3 M all-patient-refined
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(APR)-DRG classification system, V20 [29] classified in
the categories low, medium, high and extreme. This pro-
prietary software package assigns a value from 1 to 4 to
each patient in each APR-DRG group, corresponding
to increasing risk of death. This score is generated using
data on age, the presence of comorbidities, and some
procedures and their interactions, thereby allowing a
meaningful risk adjustment tool for outcome analyses.
Hospital volume was classified into three classes
according to annual caseload of colorectal surgical resec-
tion procedures (≤10, 11–25 and >25 for rectal cancer
and <25, 26–60 and >60 for colon cancer), based on
categories presented in the recommendations of the
regional guidelines [16]. Hospitals were also categorized
according to the presence of a RT service.
For each patient, accessibility to preoperative RT was
measured as the distance between their residence and
the nearest RT service, by car and under normal traffic
conditions, [30]. Three categories were defined: same
city or less than 15 minutes; 15 to less than 30 minutes;
30 minutes or more.
Outcomes
Three indicators of quality of care were selected: the
proportions of rectal cancer patients who received pre-
operative RT or abdominoperineal (AP) resection, and
the proportion of all colorectal cancer patients who died
post-operatively in hospital.
Statistical analysis
Random-intercept logistic regression models were used
to analyze data, accounting for within-hospital outcome
correlation. The logistic models included patients’ age
(≤60, 61–70, 71–80 or >80 years old), gender, education
level (categorized as ‘secondary or more’, ‘intermediate’, ‘pri-
mary’ or ‘unknown’), marital status (classified as ‘married’,
‘unmarried’: single, separated, divorced, or widowed, and
‘unknown’) and year of admission. Given the strong cor-
relation between APR-DRG risk-of-mortality score, tumor
stage and comorbidity (Charlson index 0, >1), these pre-
dictors were not included in the models simultaneously.
The results are expressed as odds ratios (OR) and 95%
confidence intervals (95%CI). Statistical analyses were
performed using STATA (version 9.2) software.
Validation
In this study the method used to identify incident colo-
rectal cancer cases included in the study cohort sample
was validated first, followed by the indicators obtained
from the HDR system.
The algorithm adopted to identify colorectal cancer
cases in this study cohort has been previously validated
using the data of the Piedmont Cancer Registry as a
reference standard (positive predictive value of the iden-
tification algorithm was 89.9%, 95%CI 87.3-92.1) [26].
The accuracy of key variables obtained from the HDR
system was further validated using a sample of 605
patients randomly selected from the same study popula-
tion as a reference standard (aged 50–69, surgically
treated during 2001–2002). In this high-resolution
sample, for each patient we abstracted and analyzed all
clinical records of surgical, and RT hospitalization iden-
tified from the HDR system (2001–2005), and found
100% reproducibility for the variables “emergency ad-
mission” and “mortality”. Furthermore 96% of the colo-
rectal cancers (n = 580) are histopathologically confirmed.
Table 1 shows the validation data for “type of cancer”,
“type of surgery” and “presence of metastasis”.
Incident colorectal cancer cases
2000-2007
(N=25,302)
Curative
(N=22,289)
Palliative
(N=1,898)
Colon cancer
(N=15,256)
Rectal cancer
(N=7,033)
Discharged from extra-regional hospitals
(N=1,115)
Figure 1 Flow chart of inclusion of colorectal cancer patients into the cohort.
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Ethical issues
The study is a retrospective clinical audit to monitor
the quality of treatment, delivered to colorectal cancer
patients. It has been conducted as recommended in the
regional guidelines [16], by the Centro di Riferimento per
l'Epidemiologia e la Prevenzione Oncologica in Piemonte
under the mandate of the regional health authority, using
preexisting encrypted administrative data. For these rea-
sons this project was exempt from ethical review.
Results
During the 8-year period, 25,302 patients with incident
colorectal cancer were identified: 24,187 were treated in
the Piedmont Region and 1,115 (4.4%) in extra-regional
hospitals.
Figure 1 depicts the flow-chart of the inclusion of
colorectal cancer patients in the cohort: 22,289 (92%)
potentially curative resections were identified in 15,256
and 7,033 colon and rectal cancer patients respectively.
Among the 5,437 rectal cancer patients who under-
went an elective intervention, 727 (13.4%) underwent
preoperative RT (Table 2). Older patients were less likely
to have RT before surgery. The probability to undergo-
ing RT was also reduced in females versus males (OR
0.77, 95%CI 0.64-0.93), and, as expected, for patients
with comorbidity (Charlson index ≥1 OR 0.73, 95%CI
0.59-0.90) or metastases (0.47, 95%CI 0.35-0.65). Fur-
thermore, there was an unexpected effect of educational
level: less-educated patients had a higher probability
of receiving neoadjuvant RT. There was a clear trend of
increasing RT over time (P for trend <0.01). Patients
were more likely to receive RT if the hospital where the
surgery was performed had a RT service (OR 2.24, 95%CI
1.77-2.85). Almost 47% of the sample lived in a city that
had a RT service, and about 16% of patients lived 30 min-
utes or more away from a RT service. The adjusted OR
to receive neoadjuvant RT tended to decrease with in-
creasing distance between a patient’s residence and RT
service (P for trend= 0.06). We performed a sensitivity
analysis, including in the model the hospital volume in-
stead of RT service. The results of this model are similar
for all variables and the adjusted OR to receive neoadju-
vant RT decreased with decreasing of the hospital volume
lower than 25 case at year (11–25 cases/year versus >25
cases/year OR 0.84, 95%CI 0.41-0.98).
Table 3 shows the proportion of patients receiving AP
resection versus other, more conservative resections,
among 7,033 rectal cancer patients, for each variable in
the model. Patients older than 70 years were more likely
to receive an AP resection compared to patients aged
60 years or younger. The probability of receiving AP
resection also increased in less-educated patients and
in hospitals with a low volume. AP resection was
performed less frequently in women (OR 0.78, 95%CI
0.69-0.89). There was no independent association between
disease stage, Charlson index, year of admission or
emergency admission and having an AP resection for
rectal cancer.
The postoperative in-hospital mortality in 22,289 colo-
rectal cancer patients is shown in Table 4. During the
Table 1 Validation results based on a survey of 605 clinical records (the high-resolution sample)
High-resolution sample (gold standard)
Colon Rectum Missing TOTAL
Colon 181 6 0 187
Type of cancer Rectum 28 390 0 418
TOTAL 209 396 0 605
Curative intent Palliative intent Missing TOTAL
Curative intent 567 32 0 599
Type of surgery Palliative intent 5 1 0 6
TOTAL 572 33 0 605
Study cohort sample AP resection Minor resection Missing TOTAL
AP resection 78 11 0 89
Surgery for rectal cancer Minor resection 15 281 5 301
Missing 0 0 0 0
TOTAL 93 292 5 390
Yes No Missing
Yes 65 2 0 65
Presence of metastasis No 25 509 6 540
Missing 0 0 0 0
TOTAL 90 511 6 605
AP: abdominoperineal.
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Table 2 Preoperative radiotherapy (RT) (followed by planned surgical admission) in 5,437 incident rectal cancer
patients
Total (N=5437) Preoperative RT (N=727) Random-effect model*
No. % OR 95% CI P
Age (years)
≤60 1,082 19.2 1 <0.001
61-70 1,707 14.8 0.71 (0.57-0.90)
71-80 1,958 11.4 0.51 (0.40-0.65)
>80 690 6.1 0.24 (0.16-0.35)
Gender
Male 3,375 14.2 1 0.03
Female 2,062 12.1 0.77 (0.64-0.93)
Educational level
Secondary or more 813 13.9 1 <0.001
Intermediate 1,244 15.3 1.35 (1.03-1.77)
Primary 2,869 11.7 1.41 (1.09-1.83)
Unknown 511 17.4 1.16 (0.79-1.71)
Marital status†
Married 3,720 13.3 1 <0.001
Unmarried 1,352 11.5 0.99 (0.80-1.23)
Unknown 365 20.8 0.84 (0.58-1.20)
Disease staging
Absence of metastases 4,836 13.9 1 0.01
Presence of metastases 601 8.8 0.47 (0.35-0.65)
Comorbidity (Charlson index)
0 4,068 14.1 1 0.01
≥1 1,369 11.2 0.73 (0.59-0.90)
Year of admission
2000 654 6.9 1 <0.001
2001 706 9.6 1.51 (1.00-2.29)
2002 617 12.3 1.96 (1.30-2.95)
2003 607 15.3 2.76 (1.85-4.11)
2004 729 16.0 2.98 (2.02-4.40)
2005 691 16.5 2.90 (1.96-4.29)
2006 738 15.2 2.82 (1.90-4.17)
2007 695 14.7 3.04 (2.03-4.56)
RT service
Absent 2,775 9.4 1 <0.001
Present 2,662 17.5 2.24 (1.77-2.85)
Distance to RT service (min.)
Same city or <15’ 2,576 15.6 1 <0.001
15’ to <30’ 1,984 12.2 0.97 (0.80-1.18)
≥30’ 877 9.6 0.82 (0.60-1.12)
Hospital volume (annual caseload)
>25 3,076 17.6 - * <0.001
11-25 1,778 6.8 - *
≤10 583 11.1 - *
*Given the correlation between hospital volume and presence of RT service, these predictors were not included in the models simultaneously.
†Unmarried includes single, separated, divorced and widowed.
OR: odds ratio, CI: confidence interval, APR-DRG: all-patient-refined-diagnosis-related group, RT: radiotherapy.
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Table 3 Abdominoperineal (AP) resection* versus other resections† (reference group) in 7,033 incident rectal cancer
patients
Total (N=7033) AP resection (N = 727) Random-effect model{
No. % OR (95% CI) P
Age (years)
≤60 1,342 17.4 1 <0.001
61-70 2,083 20.7 1.10 (0.91-1.33)
71-80 2,536 23.9 1.30 (1.08-1.56)
>80 1,072 24.6 1.38 (1.11-1.71)
Gender
Male 4,275 23.0 1 0.002
Female 2,758 19.9 0.78 (0.69-0.89)
Educational level
Secondary or more 969 17.7 1 <0.001
Intermediate 1,516 19.2 1.11 (0.90-1.38)
Primary 3,796 23.9 1.40 (1.16-1.70)
Unknown 752 22.1 1.29 (0.97-1.70)
Marital status
Married 4,651 21.3 1 0.002
Unmarried} 1,854 24.2 1.17 (1.02-1.35)
Unknown 528 17.6 0.83 (0.63-1.10)
OPE{
No 5,437 22.5 1 0.05
Yes 1,596 19.6 0.87 (0.75-1.01)
Disease staging
Absence of metastases 6,180 21.8 1 0.82
Presence of metastases 853 22.3 1.11 (0.93-1.32)
Comorbidity (Charlson index)
0 5,174 21.5 1 0.24
≥1 1,859 22.8 1.01 (0.89-1.16)
Year of admission
2000 861 23.0 1 0.04
2001 887 23.9 1.12 (0.89-1.41)
2002 789 23.7 1.06 (0.84-1.35)
2003 825 19.1 0.87 (0.68-1.11)
2004 961 20.0 0.92 (0.73-1.16)
2005 906 22.2 1.02 (0.80-1.28)
2006 923 23.4 1.08 (0.86-1.36)
2007 881 19.4 0.85 (0.67-1.09)
Hospital volume (annual caseload)
>25 3,688 20.6 1 0.001
11-25 2,560 22.1 1.03 (0.81-1.31)
≤10 785 26.6 1.37 (1.03-1.82)
*ICD9: 48.5, 48.62. †ICD9: 45.4x-45.8x, 48.3x-48.4x, 48.61, 48.63-48.69.
{Cases with obstruction or perforation or in emergency admission were classified in the OPE category.
}Unmarried includes single, separated, divorced and widowed.
OR: odds ratio, CI: confidence interval, APR-DRG: all-patient-refined-diagnosis-related group, OPE: obstruction, perforation or emergency admission.
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Table 4 Postoperative in-hospital mortality in 22289 incident colorectal cancer patients after curative surgery
Total (N=22289) Unadjusted mortality Random-effect model*
No. % OR 95% CI P
Age (years)
≤60 3,910 1.0 1
61-70 6,224 1.9 1.76 (1.20-2.57) <0.001
71-80 8,124 4.0 2.30 (1.61-3.28)
>80 4,031 8.9 3.34 (2.33-4.79)
Gender
Male 12,309 4.0 1 0.36
Female 9,980 3.5 0.71 (0.60-0.84)
Educational level
Secondary or more 3,165 1.2 1 <0.001
Intermediate 4,745 2.6 1.14 (0.82-1.58)
Primary 11,625 4.4 1.25 (0.95-1.67)
Unknown 2,754 5.2 1.60 (1.10-2.32)
Marital status
Married 14,221 3.1 1 <0.001
Unmarried 6,212 5.0 1.32 (1.09-1.59)
Unknown 1,856 5.5 1.65 (1.20-2.29)
OPE
No 14,558 1.8 1 <0.001
Yes 7,731 7.5 1.54 (1.29-1.85)
Disease staging
Absence of metastases 19,064 3.5 - <0.001
Presence of metastases 3,225 5.7 -
Comorbidity (Charlson index)
0 16,145 3.2 - <0.001
≥1 6,144 5.4 -
Year of admission
2000 2,458 4.1 1 0.55
2001 2,583 3.4 0.82 (0.59-1.14)
2002 2,651 4.1 0.95 (0.69-1.29)
2003 2,687 3.9 0.75 (0.55-1.03)
2004 2,924 4.4 0.77 (0.57-1.05)
2005 2,930 3.3 0.53 (0.38-0.73)
2006 3,006 3.5 0.54 (0.39-0.74)
2007 3,050 3.6 0.49 (0.34-0.68)
Tumor site
Colon 15,256 4.1 1 <0.001
Rectum 7,033 3.1 1.05 (0.87-1.27)
Hospital volume (annual caseload)
>60 9,371 3.5 1 0.10
26-60 9,430 3.9 0.87 (0.64-1.19)
<25 3,488 4.3 1.14 (0.76-1.69)
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study period, 841 patients died in the hospital after a
surgery with curative intent. The median length-of-stay
in the hospital after surgery was 10 days (interquartile
range 5 days) and 11 days (interquartile range 18 days)
for deceased and alive colon cancer patients respectively,
and 11 days (interquartile range 6 days) and 12 days
(interquartile range 19 days) for deceased and alive
colon cancer patients respectively. The odds of dying in
hospital in older patients, notably the 71-80-year and
over-80-year groups, was two-to-three times higher
compared to patients aged 60 years or younger. Patients
at higher risk of postoperative in-hospital mortality were
male (females versus males OR 0.71, 95%CI 0.60-0.84),
unmarried or with unknown marital status (OR 1.32,
95%CI 1.09-1.59 and OR 1.65, 95%CI 1.20-2.29 respect-
ively), and with an emergency admission (OR 1.54, 95%CI
1.29-1.85). Furthermore, there was a trend of decreasing
mortality risk over time. After adjustment for other vari-
ables, hospital volume, as measured by annual caseload,
did not show any effect on mortality.
Discussion
This study focused on the relationship between social,
clinical and hospital characteristics and postoperative in-
hospital mortality after treatment for colorectal cancer.
For rectal cancer patients only, the associations of such
factors with the use of neoadjuvant RT and AP resection
rates were also investigated.
In our population, older people with rectal cancer were
less frequently treated with preoperative RT, were more
likely to undergo AP resections and to die during
hospitalization. A reason for the lower rate of preoperative
RT may be that elderly patients were excluded from RT,
either for medical reasons or as a consequence of difficult
accessibility to RT facilities [31]. Previous studies suggested
that elderly patients are usually diagnosed at advanced
stages [32]. In addition, the older patients of the cohort
present with a higher burden of comorbidities, which
could also explain the lower probability to undergo a more
conservative surgery, and the higher in-hospital mortality.
Male patients in our study underwent AP more often,
had a higher in-hospital mortality and were more likely
to have RT before rectal cancer surgery. Previous studies
observed that survival after colorectal cancer resection is
better in women than in men [33,34]. In particular, in a
recent study in the United States, Paulson noted that
women have a longer survival compared with men –
despite the fact that they are more likely to have an
emergency admission and at an older age – and they
receive less aggressive medical treatment [35].
In the population of the Piedmont Region, marital sta-
tus had a clear effect on in-hospital mortality, with un-
married patients and those with unknown marital status
showing a significantly higher mortality risk than mar-
ried patients. A possible explanation for this difference is
diagnostic delay, which may affect the extent of disease
at diagnosis, or differences in access to health care ser-
vices [36]. However, a protective effect of family care-
givers during hospitalization cannot be excluded.
Less-educated patients have a significantly higher
probability to undergo preoperative RT. This is an unex-
pected finding, as less-educated people also have a
higher risk to undergo AP resection and to die after
colorectal surgery than more-educated people. Access to
public health care services is provided free in Italy, and
hospital admission is not clearly determined by social
class [37]. Nevertheless, the higher rate of preoperative
RT in less-educated patients may reflect a residual con-
founding by disease stage, with a lower proportion of
early, screen-detected cases in this group (without indica-
tion for RT), as we already reported some years ago [38].
An extensive body of literature suggests that a hospi-
tal’s surgical volume of surgeries and hospital proce-
dures is predictive of short- and long-term outcomes in
patients undergoing complex medical and surgical proce-
dures [22,39-42]. In our study, a hospital’s annual case-
load was a predictor of the type of surgery performed
among rectal cancer patients but not of in-hospital mor-
tality. Finally, we found the presence of a RT service in
the hospital where surgery was performed, and the dis-
tance between the patient’s residence and the nearest RT
facility, to be two important predictive factors for pre-
operative RT. Most of these results, such as the role of
comorbidity [43], hospital volume [39] and distance to
Table 4 Postoperative in-hospital mortality in 22289 incident colorectal cancer patients after curative surgery
(Continued)
APR-DRG risk-of-mortality score
Low 12,740 0.8 1 <0.001
Medium 7,869 3.9 4.47 (3.54-5.66)
High 1,359 19.1 25.77 (19.80-33.54)
Extreme 321 56.7 153.03 (109.81-213.27)
*Given the correlation between APR-DRG risk-of-mortality score, tumor stage and comorbidity score these predictors were not included in the models
simultaneously.
{Unmarried includes single, separated, divorced and widowed.
OR: odds ratio; CI: confidence interval; APR-DRG: all-patient-refined-diagnosis-related group; OPE: obstruction, perforation or emergency admission.
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RT facilities [42], have been reported by other studies,
mostly from the United States. As such, this study has
its added value in confirming the importance of these
factors to the equity and quality of care in a Southern
European country with an open-access public health
care system.
The present study shares the limitations of research
that uses routinely-collected data with respect of the
completeness and accuracy of data coding and the use of
limited clinical variables. In particular the lack of infor-
mation on cancer stage could cause an underestimation
of the proportion of incident rectal cancer that received
the RT. Nevertheless, we performed an accurate valid-
ation of variables with the local cancer registry and a
high-resolution clinical sample that confirmed the reli-
ability of these administrative data. On the other hand,
the major strength of our study is the population cover-
age and the availability of standardized data for a rela-
tively long period.
Conclusion
The study provides evidence of the importance of social,
clinical and hospital patient characteristics on the equity
and quality of care in a Southern European country with
an open-access public health care system. Furthermore
it offers an example of how these factors allow for the
maintenance of a monitoring system that can be used to
assess key indicators of process and outcome of initial
treatment of colorectal cancer over time, with acceptable
accuracy, at minimal cost.
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